Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 10. July 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8995  Previews Next
   
   Articles 1 - 20 / 179895  
   
Moderately hypofractionated intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: five-year results from a single-institution study in Japan.
Int J Clin Oncol
Anno W, Aoki S, Kunogi H, Ogura Y, Kamima T, Kozuka T, Numao N, Ebara T, Yonese J, Yoshioka Y.
PMID: 42430105 [PubMed - as supplied by publisher]


ASO Visual Abstract: Outcomes of Neoadjuvant Radiotherapy Followed by Robotic Radical Prostatectomy in High-Risk Locally Advanced Prostate Cancer: A Prospective Pilot Study.
Ann Surg Oncol
Tseng CS, Chang CK, Li HJ, Liu YT, Huang SW, Huang CY, Cheng JC.
PMID: 42429901 [PubMed - as supplied by publisher]


Haematological, renal and hepatic toxicity profiles of infusional 5-fluorouracil versus capecitabine in African gastrointestinal cancer patients: a retrospective cohort study.
Ecancermedicalscience
Mazhindu TA, Ndlovu N, Borok MZ, Grimes K, Masimirembwa C.
PMID: 42428813 [PubMed]


Combining VEGFR tyrosine kinase inhibitors and PD-1/PD-L1 inhibitors versus VEGFR tyrosine kinase inhibitors monotherapy in renal cell carcinoma: a target trial emulation.
medRxiv
Shi D, Li X, Chen Y, Chen Y, Song Q, Su J.
PMID: 42428070 [PubMed]


A genome-wide Mendelian randomization study focusing on endoplasmic reticulum stress reveals novel genetic markers for renal cell carcinoma.
Oncol Lett
Gao B, Li Z, Shi J, Shen J.
PMID: 42427927 [PubMed]


Integration of sarcopenia screening into radiotherapy planning: Validation of a time-efficient SMI measurement method using MIM software in prostate cancer.
J Appl Clin Med Phys
De Bruyn P, Coquelet N, Ferreira P, Michel M, Descamps T, Van den Begin R, Van Gestel D, Preiser JC.
PMID: 42427162 [PubMed - indexed for MEDLINE]


New Strategies to Uncover Genes Involved in the Development of Prostate Cancer in Families with Multiple Cases.
Methods Mol Biol
Chica-Redecillas L, Álvarez-González B, Cuenca-López S, Alvarez-Cubero MJ, Martínez-González LJ.
PMID: 42426470 [PubMed - indexed for MEDLINE]


Integrating MRI-based tumour staging within the TNM classification system in modern prostate cancer management.
Insights Imaging
Agrotis G, Purysko A, Padhani A, Jäderling F, Villeirs G, Withey SJ, de Rooij M, Barrett T, Schoots IG.
PMID: 42426432 [PubMed]


Prognostic factors and the role of pelvic lymph node dissection in oligometastatic prostate cancer: a multicenter exploratory study.
Surg Endosc
Hu J, Yuan Y, Zou X, Liu X, Liu W, Dong Y, Wang B, Fu B.
PMID: 42426390 [PubMed - as supplied by publisher]


Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer.
Nat Rev Urol
Fletcher SA, Pickersgill NA, Osorio JC, McHugh DJ, Nagar H, Kole T, Janopaul-Naylor J, Lacuna K, Eastham JA, Touijer KA, Fainberg JS, Scher HI, Ehdaie B, Dallos MC, Gaffney CD.
PMID: 42426291 [PubMed - as supplied by publisher]


Unmet needs in penile cancer: Review and perspectives from the Global Society of Rare Genitourinary Tumors.
Urol Oncol
Medina LG, Jaime-Casas S, Eskenazi F, Dugarte J, Chahoud J, Spiess PE.
PMID: 42425883 [PubMed - as supplied by publisher]


Re: Murthy V, Maitre P, Pal M, et al. Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-invasive Bladder Cancer. J Clin Oncol. In press. http://dx.doi.org/10.1200/JCO-25-02093.
Eur Urol
Miao J, Yi X.
PMID: 42425857 [PubMed - as supplied by publisher]


[How to prevent and manage PARP inhibitor-related hematological toxicities in prostate cancer?].
Bull Cancer
Cassuto O, Schmitt A, Helissey C, Gobert A, Mathieu R, Bouteleux C, Mourey L, Jovenin N, Joly F.
PMID: 42425824 [PubMed - as supplied by publisher]


Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment.
Eur Urol Focus
Hoeh B, Mazzucato G, Tennstedt P, Ekrutt J, Preisser F, Budäus L, Maurer T, Graefen M, Tilki D, Mandel P, Steuber T.
PMID: 42425812 [PubMed - as supplied by publisher]


Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
J Natl Compr Canc Netw
Mahmoud N, Mustasam A, Miller J, Lakhram A, Hatoum F, Thompson ZJ, Kim Y, Souza GR, Johnson JS, Safa H, Spiess PE, Chahoud J.
PMID: 42425150 [PubMed - as supplied by publisher]


Assessing tumor hypoxia in prostate cancer using intravoxel incoherent motion: a hypothesis-generating study.
Clin Radiol
Alagbe OA, Pascoal AM, Chahud F, Colli LM, Borges Dos Reis R, Muglia VF.
PMID: 42424761 [PubMed - as supplied by publisher]


The significance of vascular endothelial growth factor and systemic inflammatory reaction in bladder cancer patients.
Cytokine
Strojny Z, Kanikowska D, Kanikowska A, Tomczak Z, Sikora W, Sato M, Strojny M, , Deja T, Br, Korybalska K.
PMID: 42424711 [PubMed - as supplied by publisher]


Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.
JCO Glob Oncol
Jobanputra K, Dhanawat A, Prakash G, Arora A, Dey S, Pawar A, Jadhav B, Menon N, Shah M, Pal M, Bakshi G, Murthy V, Maitre P, Popat P, Sable N, Ringe-Katdare A, Agrawal A, Menon S, Noronha V, Prabhash K, Joshi A.
PMID: 42424570 [PubMed - indexed for MEDLINE]


Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world study.
Jpn J Clin Oncol
Tsuru I, Taguchi S, Tanaka R, Kawai T, Kaneko T, Nakamura Y, Miyauchi Y, Hoshina H, Obinata D, Koshiba M, Shiozaki M, Takahashi J, Kano M, Naito A, Suda S, Noda M, Sugiyama N, Tanaka T, Uemura Y, Miyakawa J, Kamei J, Kakutani S, Niimi A, Yamada Y, Sato Y, Yamada Y, Nishimatsu H, Murata T, Takahashi S, Takada T, Akiyama Y, Takahashi S, Fujimura T, Fukuhara H, Nakagawa T, Kume H.
PMID: 42424546 [PubMed - as supplied by publisher]


Platinum-based chemotherapy in metastatic castration-resistant prostate cancer: a narrative review and dual stratification framework based on HRR genotype and aggressive-variant/neuroendocrine phenotype.
Int Urol Nephrol
Chen H, Wang Y, Ding Y, Qu M, Gao X.
PMID: 42423955 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 179895    Page 1 of 8995  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1